Jijia Hu

2.1k total citations · 1 hit paper
35 papers, 808 citations indexed

About

Jijia Hu is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Jijia Hu has authored 35 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 16 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Jijia Hu's work include Renal Diseases and Glomerulopathies (13 papers), Mitochondrial Function and Pathology (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Jijia Hu is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Mitochondrial Function and Pathology (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Jijia Hu collaborates with scholars based in China. Jijia Hu's co-authors include Guohua Ding, Jun Feng, Zhaowei Chen, Zijing Zhu, Wei Liang, Yiqiong Ma, Qian Yang, Xueyan Yang, Yanqin Fan and Zongwei Zhang and has published in prestigious journals such as Nature Communications, Free Radical Biology and Medicine and Kidney International.

In The Last Decade

Jijia Hu

34 papers receiving 804 citations

Hit Papers

Transition of acute kidne... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jijia Hu China 18 397 294 123 98 83 35 808
Jun Feng China 18 363 0.9× 243 0.8× 108 0.9× 74 0.8× 80 1.0× 24 716
Zijing Zhu China 18 402 1.0× 229 0.8× 114 0.9× 83 0.8× 62 0.7× 45 789
Tomohito Doke United States 16 427 1.1× 328 1.1× 141 1.1× 86 0.9× 59 0.7× 24 937
Dhanunjay Mukhi United States 16 371 0.9× 299 1.0× 138 1.1× 89 0.9× 53 0.6× 27 853
Chun‐Tao Lei China 16 353 0.9× 310 1.1× 110 0.9× 86 0.9× 46 0.6× 26 908
Yiqiong Ma China 14 276 0.7× 199 0.7× 79 0.6× 66 0.7× 69 0.8× 19 596
Monica Locatelli Italy 18 325 0.8× 399 1.4× 107 0.9× 202 2.1× 49 0.6× 33 1.1k
Danyi Yang China 14 260 0.7× 329 1.1× 163 1.3× 81 0.8× 66 0.8× 28 720
Shuqin Mei China 13 233 0.6× 160 0.5× 115 0.9× 60 0.6× 25 0.3× 22 531
Yanlin Yu China 11 187 0.5× 242 0.8× 57 0.5× 60 0.6× 30 0.4× 15 550

Countries citing papers authored by Jijia Hu

Since Specialization
Citations

This map shows the geographic impact of Jijia Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jijia Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jijia Hu more than expected).

Fields of papers citing papers by Jijia Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jijia Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jijia Hu. The network helps show where Jijia Hu may publish in the future.

Co-authorship network of co-authors of Jijia Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jijia Hu. A scholar is included among the top collaborators of Jijia Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jijia Hu. Jijia Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xiao‐Xiao, Weiwei Li, Xinghua Chen, et al.. (2025). USP22 promotes angiotensin II-induced podocyte injury by deubiquitinating and stabilizing HMGB1. Cellular Signalling. 131. 111771–111771. 5 indexed citations
2.
Zhu, Zijing, Yun Cao, Qian Yang, et al.. (2025). CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease. Nature Communications. 16(1). 1528–1528. 10 indexed citations
3.
Hao, Yiqun, Jijia Hu, Qian Guan, et al.. (2025). Sirt6 deficiency exacerbates angiotensin II-induced lipid nephrotoxicity by affecting PLD6-derived cardiolipin metabolism in podocytes. Cellular Signalling. 133. 111858–111858. 1 indexed citations
4.
Wang, Juan, et al.. (2025). Dapagliflozin attenuates diabetes-induced podocyte lipotoxicity via ERRα-Mediated lipid metabolism. Free Radical Biology and Medicine. 234. 178–191. 3 indexed citations
5.
Wang, Juan, Jijia Hu, Qian Guan, et al.. (2025). APT1-derived depalmitoylation of CD36 alleviates diabetes-induced lipotoxicity in podocytes. International Journal of Biological Sciences. 21(9). 3852–3866.
6.
Chen, Xinghua, Zijing Zhu, Yiqun Hao, et al.. (2024). STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury. Cell Death and Disease. 15(3). 217–217. 42 indexed citations
7.
Hu, Jijia, Zijing Zhu, Yiqun Hao, et al.. (2024). RBBP6‐Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney Disease. Advanced Science. 11(46). e2405153–e2405153. 3 indexed citations
8.
Hu, Jijia, et al.. (2023). LRH‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2‐mediated glutaminolysis. Cell Proliferation. 56(11). e13479–e13479. 8 indexed citations
9.
Chen, Zhaowei, Zijing Zhu, Wei Liang, et al.. (2023). Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement. Kidney International. 103(4). 735–748. 38 indexed citations
10.
Chen, Zhaowei, et al.. (2023). Interplay of lipid metabolism and inflammation in podocyte injury. Metabolism. 150. 155718–155718. 29 indexed citations
11.
Chen, Zhaowei, Zijing Zhu, Yiqun Hao, et al.. (2022). Angiotensin II induces podocyte metabolic reprogramming from glycolysis to glycerol-3-phosphate biosynthesis. Cellular Signalling. 99. 110443–110443. 6 indexed citations
12.
Hu, Jijia, Zijing Zhu, Zhaowei Chen, et al.. (2022). Alteration in Rab11‐mediated endocytic trafficking of LDL receptor contributes to angiotensin II‐induced cholesterol accumulation and injury in podocytes. Cell Proliferation. 55(6). e13229–e13229. 8 indexed citations
13.
Chen, Zhaowei, Wei Liang, Jijia Hu, et al.. (2022). Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1‐Drp1 signalling pathway. Cell Proliferation. 55(10). e13296–e13296. 21 indexed citations
14.
Zhu, Zijing, Jijia Hu, Zhaowei Chen, et al.. (2022). Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism. 131. 155194–155194. 108 indexed citations breakdown →
15.
Yang, Xueyan, Jun Feng, Wei Liang, et al.. (2021). Roles of SIRT6 in kidney disease: a novel therapeutic target. Cellular and Molecular Life Sciences. 79(1). 53–53. 33 indexed citations
16.
Ma, Yiqiong, Qian Yang, Jijia Hu, et al.. (2020). AKAP1 mediates high glucose‐induced mitochondrial fission through the phosphorylation of Drp1 in podocytes. Journal of Cellular Physiology. 235(10). 7433–7448. 53 indexed citations
17.
Hu, Jijia, et al.. (2020). Preparedness is Essential for Western Pacific Islands During the COVID-19 Pandemic. Disaster Medicine and Public Health Preparedness. 14(6). e26–e30. 12 indexed citations
18.
Yang, Qian, Jijia Hu, Yingjie Yang, et al.. (2020). Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes. Theranostics. 10(16). 7465–7479. 52 indexed citations
19.
Hu, Jijia, Qian Yang, Zhaowei Chen, et al.. (2019). Small GTPase Arf6 regulates diabetes‐induced cholesterol accumulation in podocytes. Journal of Cellular Physiology. 234(12). 23559–23570. 19 indexed citations
20.
Feng, Jun, Yiqiong Ma, Zhaowei Chen, et al.. (2019). Mitochondrial pyruvate carrier 2 mediates mitochondrial dysfunction and apoptosis in high glucose-treated podocytes. Life Sciences. 237. 116941–116941. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026